MannkindLogoStackedPreferd.jpg
MannKind Corporation Reports 2020 Fourth Quarter and Full Year Financial Results
February 25, 2021 08:00 ET | MannKind
Conference Call to Begin Today at 9:00 AM ET 4Q 2020 Afrezza Net Revenue of $10.1 million; +30% vs. 4Q 2019     • Sequential Quarter Growth +38% vs. 3Q 20202020 Total Revenues of $65.1 million     •...
MannkindLogoStackedPreferd.jpg
MannKind Corporation to Participate in 2021 SVB Leerink Global Healthcare Conference
February 18, 2021 17:00 ET | MannKind
WESTLAKE VILLAGE, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for...
MannkindLogoStackedPreferd.jpg
MannKind Corporation to Hold 2020 Fourth Quarter and Full Year Financial Results Conference Call on February 25, 2021
February 18, 2021 09:00 ET | MannKind
WESTLAKE VILLAGE, Calif., Feb. 18, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) will release its 2020 fourth quarter and full year financial results and its management will host a...
MannkindLogoStackedPreferd.jpg
MannKind Corporation to Participate in H.C. Wainwright Bioconnect 2021 Conference
January 04, 2021 17:00 ET | MannKind
WESTLAKE VILLAGE, Calif., Jan. 04, 2021 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD), a company focused on the development and commercialization of inhaled therapeutic products for...
MannkindLogoStackedPreferd.jpg
MannKind and Vertice to Co-Promote Thyquidity™ (levothyroxine sodium) Oral Solution
December 17, 2020 16:44 ET | MannKind
WESTLAKE VILLAGE, Calif. and NEW PROVIDENCE, N.J., Dec. 17, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) and Vertice Pharma today announced that they have entered into a co-promotion...
MannkindLogoStackedPreferd.jpg
James S. Shannon Transitions to Chairman of the Board of Directors for MannKind
December 10, 2020 08:00 ET | MannKind
WESTLAKE VILLAGE, Calif., Dec. 10, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) today announced that James S. Shannon, M.D., MRCP (UK) has been named the new Chairman of the Board of...
MannkindLogoStackedPreferd.jpg
MannKind Expands Its Pipeline with the Acquisition of QrumPharma, Inc.
December 07, 2020 09:20 ET | MannKind
WESTLAKE VILLAGE, Calif., Dec. 07, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (Nasdaq: MNKD) today announced that it has acquired QrumPharma, Inc., a privately held pharmaceutical company...
MannkindLogoStackedPreferd.jpg
MannKind and MidCap Amend Credit Facility
December 01, 2020 08:00 ET | MannKind
$10 million funded immediately$25 million available upon TreT FDA approvalInterest-only period extended to September 2022 WESTLAKE VILLAGE, Calif., Dec. 01, 2020 (GLOBE NEWSWIRE) -- MannKind...
MannkindLogoStackedPreferd.jpg
Sabrina Kay Appointed to MannKind Board of Directors
November 30, 2020 08:00 ET | MannKind
WESTLAKE VILLAGE, Calif., Nov. 30, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) today announced that Sabrina Kay Ed.D. has been appointed to its Board of Directors, effective December...
MannkindLogoStackedPreferd.jpg
MannKind Receives Fourth $12.5 Million Milestone Payment from United Therapeutics
November 19, 2020 17:00 ET | MannKind
WESTLAKE VILLAGE, Calif., Nov. 19, 2020 (GLOBE NEWSWIRE) -- MannKind Corporation (NASDAQ:MNKD) today announced that it has achieved the final development milestone under its licensing and...